Pharmacogenomics of Asparaginase Induced Hepatotoxicity
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Acute Lymphoblastic Leukemia
Related studies linked through entity extraction aliases.
Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351
- Status
- COMPLETED
- Phase
- PHASE1
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
- Status
- RECRUITING
- Phase
- PHASE1
Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome
- Status
- SUSPENDED
- Phase
- PHASE1
Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
- Status
- COMPLETED
- Phase
- PHASE3
Nutritional Status in Children With ALL in Guatemala
- Status
- COMPLETED
- Phase
- N/A
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia
- Status
- COMPLETED
- Phase
- NA
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Anti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Anti-CD19 CAR-T Therapy Combine With HSCT to Treat MRD+ B-cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
- Status
- TERMINATED
- Phase
- PHASE2
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1
Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- N/A
Cladribine in Combination With GAP in Patients With Refractory/Relapsed Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
- Status
- RECRUITING
- Phase
- PHASE2